(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

IPHARMACIST 360

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

IPHARMACIST 360

ST13

US500000088372315

Classe

9, 41, 42, 44

Pedido

88372315

Registro

7394482

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

64

Atualização mais recente

28/05/2024

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 41, 42, 44

Data de depósito

04/04/2019

Data de registro

28/05/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

28/05/2024

Última transação

28/05/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

03

Localização do titular

Toronto, Ontario, CA

Examinador

BERNS, LEE-ANNE

Unidade examinadora

M90

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

APOTEX INC.
Apotex Technologies Inc.

Representantes

Jessica G. Kraver Katten Muchin Rosenman LLP

Classificação técnica

Classes Nice

Classe 9Classe 41Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Downloadable computer application software for mobile phonesportable media playershandheld tabletscomputerssoftware for internet and/or mobile access to medical contentmedical calculatorshealthcare news and other pharmacy management resources directed to enhance patient care and advance pharmacy practice; Downloadable computer softwaresoftware applications allowing healthcare professionalspharmaciststheir assistants and sales employees to access medical and pharmaceutical related reference material for use in advising on drug usedrug interactions and medical counselling stored in a centralized databases in real timeusing a computer or mobile computer device; Downloadable electronic newslettersin the field of patient caremedicationhealthpharmaceuticalmedical and clinical related questions and issues

Classe 41

Providing non-downloadable electronic newslettersin the field of patient caremedicationhealthpharmaceuticalmedical and clinical related questions and issues

Classe 42

Providing online-non-downloadable computer application software for mobile phonesportable media playershandheld tabletscomputerssoftware for internet and/or mobile access to medical contentmedical calculatorshealthcare news and other pharmacy management resources directed to enhance patient care and advance pharmacy practice; Providing on-linenondownloadable computer softwaresoftware applications allowing healthcare professionalspharmaciststheir assistants and sales employees to access medical and pharmaceutical related reference material for use in advising on drug usedrug interactions and medical counselling stored in a centralized databases in real timeusing a computer or mobile computer device

Classe 44

Advisory services in the nature of medical and pharmaceutical consultation in the fields of patient caremedicationhealthpharmaceuticalmedical and clinical related questions and issues; Digital platform in the nature of an online database of patient medical information that provides information relating to patient caremedicationmedicalhealthpharmaceutical and clinical related questions and issues

Publicações

Histórico de despachos e eventos da marca no USPTO.

64 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

28/05/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

28/05/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/03/2024

PUBO

PUBLISHED FOR OPPOSITION

12/03/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

21/02/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

21/02/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/02/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

31/12/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

31/12/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

28/12/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/11/2023

GNRT

NON-FINAL ACTION E-MAILED

01/11/2023

CNRT

NON-FINAL ACTION WRITTEN

01/11/2023

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

19/07/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

19/07/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

19/07/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

19/07/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

19/07/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

19/07/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

19/07/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

23/06/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

23/06/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

21/06/2023

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

21/03/2023

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

21/03/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

21/12/2022

GNRT

NON-FINAL ACTION E-MAILED

21/12/2022

CNRT

NON-FINAL ACTION WRITTEN

21/12/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

21/11/2022

GNSL

LETTER OF SUSPENSION E-MAILED

21/11/2022

CNSL

SUSPENSION LETTER WRITTEN

21/11/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/11/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/11/2022

ALIE

ASSIGNED TO LIE

07/11/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

31/10/2022

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

06/10/2022

GNSI

INQUIRY TO SUSPENSION E-MAILED

06/10/2022

CNSI

SUSPENSION INQUIRY WRITTEN

06/10/2022

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

23/08/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

17/02/2022

GNSL

LETTER OF SUSPENSION E-MAILED

17/02/2022

CNSL

SUSPENSION LETTER WRITTEN

17/02/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

15/01/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

15/01/2022

ALIE

ASSIGNED TO LIE

13/01/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

12/01/2022

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

10/08/2021

GNSI

INQUIRY TO SUSPENSION E-MAILED

10/08/2021

CNSI

SUSPENSION INQUIRY WRITTEN

10/08/2021

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

21/01/2021

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

07/07/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

22/12/2019

GNSL

LETTER OF SUSPENSION E-MAILED

22/12/2019

CNSL

SUSPENSION LETTER WRITTEN

22/12/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/12/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/12/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/12/2019

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/07/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

19/06/2019

GNRT

NON-FINAL ACTION E-MAILED

19/06/2019

CNRT

NON-FINAL ACTION WRITTEN

19/06/2019

DOCK

ASSIGNED TO EXAMINER

14/06/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

22/04/2019

NWAP

NEW APPLICATION ENTERED

08/04/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace IPHARMACIST 360 ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.